When to start antiretroviral therapy in HIV-associated tuberculosis.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it.

1. Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066).Infection · 2013
   Guideline
2. Use of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: a systematic review.PloS one · 2012
   Pooled it
3. Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (toxoplasmosis, Pneumocystis jirovecii-pneumonia): a prospective, randomized, open-label multicenter study (IDEAL-study).AIDS research and therapy · 2019
   Trial
4. Clinical Outcomes of Patients With Drug-Resistant Tuberculous Meningitis Treated With an Intensified Antituberculosis Regimen.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
   Trial
5. Regulatory T Cells Kinetics in Immune Reconstitution Inflammatory Syndrome in HIV-Tuberculosis Co-Infected Individuals.Journal of molecular and clinical medicine · 2025
   Article
6. Prediction of pulmonary tuberculosis treatment outcome in a sub-Saharan African context.Journal of public health in Africa · 2023
   Article
7. Global HIV neurology: a comprehensive review.AIDS (London, England) · 2019
   Review
8. Human Immunodeficiency Virus in the Brain-Culprit or Facilitator?Infectious diseases · 2018
   Review
9. Impact of combination antiretroviral therapy initiation on adherence to antituberculosis treatment.Southern African journal of HIV medicine · 2015
   Article
10. Immune reconstitution inflammatory syndrome in HIV-infected patients.HIV/AIDS (Auckland, N.Z.) · 2015
    Review
11. Central nervous system immune reconstitution inflammatory syndrome.Current infectious disease reports · 2013
    Article
12. Risk factors for mortality in Malawian children with human immunodeficiency virus and tuberculosis co-infection.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2013
    Article
13. Initiation of antiretroviral therapy in HIV-infected tuberculosis patients in rural Kenya: an observational study.Tropical medicine & international health : TM & IH · 2013
    Article
14. Timing of antiretroviral therapy in Cambodian hospital after diagnosis of tuberculosis: impact of revised WHO guidelines.Bulletin of the World Health Organization · 2013
    Article
15. Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2013
    Article

Corrections and comments

• Commented on by
  Timing of antiretroviral therapy for HIV-1-associated tuberculosis.2012
• Comment on
  Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.2011
• Comment on
  Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.2011
• Comment on
  Integration of antiretroviral therapy with tuberculosis treatment.2011

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as